Jonathan Edwards

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 01:48, December 4, 2019 by Kmdenmark (talk | contribs) (added citation; converted citation; reordered sections)
Source: phoenixrising.me

Professor Jonathan Edwards is an Emeritus Professor of Connective Tissue Medicine at University College London (UCL) in the UK. Professor Edwards was instrumental in the discovery of the use of B-cell depletion therapy (Rituximab) to treat rheumatoid arthritis.[1]

B-cell depletion ME/CFS research[edit | edit source]

Professor Edwards became interested in the possible use of Rituximab to treat ME/CFS after attending the Invest in ME International ME Conference in May 2013 and subsequently agreed to advise on and lead the effort.[2]

Committees and boards[edit | edit source]

Phoenix Rising[edit | edit source]

Professor Edwards once served on the board of directors of the online patient community Phoenix Rising.[3]

Science for ME[edit | edit source]

Professor Edwards is currently active on the Science for ME forum. [4]

Advocacy[edit | edit source]

Open Letters to The Lancet[edit | edit source]

In response to The Lancet's publication of the controversial PACE trial in 2011, three open letters to the editor of The Lancet urged the editor, Richard Horton, to commission a fully independent review of the PACE trial. Dr. Edwards signed all three. The first, written in 2015, was signed by Dr. Edwards and five of his colleagues. In 2016, thirty-six additional colleagues in the ME/CFS field, signed the second letter. In 2018, a resubmitted letter had over one hundred signatories.

Publications related to ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "B cell depletion: an effective therapy in rheumatoid arthritis". www.ucl.ac.uk. Retrieved August 30, 2018.
  2. "Interview: Professor Jonathan Edwards on the UK Rituximab trial". Phoenix Rising ME / CFS Forums. Retrieved December 4, 2019.
  3. "Phoenix Rising Adds Two New Board Members". Phoenix Rising. October 6, 2014. Retrieved August 30, 2018. Cite has empty unknown parameter: |dead-url= (help)
  4. Edwards, Jonathan. "Science for ME Profile Page". s4me.info. Cite has empty unknown parameter: |dead-url= (help)
  5. Tuller, David (November 13, 2015). "An open letter to Dr. Richard Horton and The Lancet". Virology Blog. Cite has empty unknown parameter: |dead-url= (help)
  6. Tuller, David (February 10, 2016). "An open letter to The Lancet, again". Virology Blog. Cite has empty unknown parameter: |dead-url= (help)
  7. Tuller, David (July 10, 2018). "Trial By Error: Yet Another Appeal to The Lancet, With More On Board". Virology Blog. Cite has empty unknown parameter: |dead-url= (help)
  8. Edwards, Jonathan C.W.; McGrath, Simon; Baldwin, Adrian; Livingstone, Mark; Kewley, Andrew (April 2, 2016). "The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem". Fatigue: Biomedicine, Health & Behavior. 4 (2): 63–69. doi:10.1080/21641846.2016.1160598. ISSN 2164-1846. PMC 4867862. PMID 27226928.
  9. Edwards, Jonathan Edwards (March 28, 2017). "PACE team response shows a disregard for the principles of science". journals.sage.pub. Journal of Health Psychology. Cite has empty unknown parameter: |dead-url= (help)
  10. "Interview: Professor Jonathan Edwards on the UK Rituximab trial". Phoenix Rising. September 3, 2013. Cite has empty unknown parameter: |dead-url= (help)
  11. "IIMEC9 Conference DVD". IIMEC9. Cite has empty unknown parameter: |dead-url= (help)
  12. Edwards, Jonathan (July 20, 2018). "Letter to Professor Watt" (PDF). meassociation.com. Cite has empty unknown parameter: |dead-url= (help)